{"celex_id": "32010D0030", "uri": "http://publications.europa.eu/resource/cellar/fb8f413e-01d2-4f3d-ac97-135fc1f3a1e9", "type": "Decision", "concepts": ["1415", "1594", "2723", "2950", "3813"], "title": "2010/30/: Commission Decision of 9 December 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 9703) (Text with EEA relevance)\n", "header": "19.1.2010 EN Official Journal of the European Union L 12/14\nCOMMISSION DECISION\nof 9 December 2009\namending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products\n(notified under document C(2009) 9703)\n(Text with EEA relevance)\n(2010/30/EU)\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on European Union and to the Treaty on the Functioning of the European Union,\nHaving regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use\u00a0(1), and in particular Article 16(f) thereof,\nHaving regard to the opinions of the European Medicines Agency, formulated on 10 January 2008 and 6 March 2008 by the Committee for Herbal Medicinal Products,\nWhereas:\n(1) \u2018Eleutherococcus senticosus (Rupr. et Maxim.) Maxim\u2019 and \u2018Echinacea purpurea (L.) Moench\u2019 comply with the requirements set out in Directive 2001/83/EC. \u2018Eleutherococcus senticosus (Rupr. et Maxim.) Maxim\u2019 and \u2018Echinacea purpurea (L.) Moench\u2019 can be considered as herbal substances, herbal preparations or combinations thereof.\n(2) It is therefore appropriate to include \u2018Eleutherococcus senticosus (Rupr. et Maxim.) Maxim\u2019 and \u2018Echinacea purpurea (L.) Moench\u2019 in the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established in Annex I to Commission Decision 2008/911/EC\u00a0(2).\n(3) Decision 2008/911/EC should therefore be amended accordingly.\n(4) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,", "main_body": ["Decision 2008/911/EC is amended as follows:\n1. Annex I is amended in accordance with Annex I to this Decision;\n2. Annex II is amended in accordance with Annex II to this Decision.", "This Decision is addressed to the Member States."], "attachments": "Done at Brussels, 9 December 2009.\nFor the Commission\nG\u00fcnter VERHEUGEN\nVice-President\n(1)\u00a0\u00a0OJ L\u00a0311, 28.11.2001, p. 67.\n(2)\u00a0\u00a0OJ L\u00a0328, 6.12.2008, p. 42.\nANNEX I\nIn Annex I to Decision 2008/911/EC, the following two substances are inserted after \u2018Calendula officinalis L.\u2019:\n\u2014 \u2018Echinacea purpurea (L.) Moench\u2019\n\u2014 \u2018Eleutherococcus senticosus (Rupr. et Maxim.) Maxim\u2019\nANNEX II\nIn Annex II to Decision 2008/911/EC, the following is inserted after the entry relating to \u2018Calendula officinalis L\u2019:\n\u2018COMMUNITY LIST ENTRY ON ECHINACEA PURPUREA (L.) MOENCH, HERBA RECENS\nScientific name of the plant\nEchinacea purpurea (L.) Moench\nBotanical family\nAsteraceae\nHerbal substance\nPurple coneflower herb\nCommon name in all EU official languages of herbal substance\nBG (b\u0103lgarski): \u043f\u0443\u0440\u043f\u0443\u0440\u043d\u0430 \u0435\u0445\u0438\u043d\u0430\u0446\u0435\u044f, \u043f\u0440\u0435\u0441\u0435\u043d \u0441\u0442\u0440\u044a\u043a\nCS (\u010de\u0161tina): \u010derstv\u00e1 na\u0165 t\u0159apatky nachov\u00e9\nDA (dansk): Purpursolhat, frisk urt\nDE (Deutsch): Purpursonnenhutkraut, frisch\nEL (ellinik\u00e1): \u03a0\u03cc\u03b1 \u0395\u03c7\u03b9\u03bd\u03ac\u03ba\u03b5\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03c0\u03bf\u03c1\u03c6\u03c5\u03c1\u03ac\u03c2\nEN (English): purple coneflower herb\nES (espa\u00f1ol): Equin\u00e1cea purp\u00farea, partes a\u00e9reas incluidas sumidades floridas\nET (eesti keel): punane siilk\u00fcbar\nFI (suomi): kaunopunahattu, tuore verso\nFR (fran\u00e7ais): parties a\u00e9riennes fra\u00eeches d\u2019\u00e9chinac\u00e9e pourpre\nHU (magyar): b\u00edbor kasvir\u00e1g vir\u00e1gos hajt\u00e1sa\nIT (italiano): Echinacea purpurea, pianta fresca\nLT (lietuvi\u0173 kalba): rausva\u017eied\u017ei\u0173 e\u017eiuoli\u0173 \u017eol\u0117\nLV (latvie\u0161u valoda): purpursarkan\u0101s ehinacejas laksti\nMT (malti): Echinacea Vjola\nNL (nederlands): rood zonnehoedkruid\nPL (polski): je\u017c\u00f3wka purpurowa, \u015bwie\u017ce ziele\nPT (portugu\u00eas): Equin\u00e1cea, partes a\u00e9reas floridas\nRO (rom\u00e2n\u0103): iarb\u00e3 proasp\u00e3t\u00e3 de Echinacea, p\u00e3l\u00e3ria soarelui\nSK (sloven\u010dina): echinacea purpurov\u00e1, \u010derstv\u00e1 v\u0148a\u0165\nSL (sloven\u0161\u010dina): sve\u017ea zel \u0161krlatne ehinaceje\nSV (svenska): r\u00f6d solhatt, f\u00e4rsk \u00f6rt\nIS (\u00edslenska): S\u00f3lhattur\nNO (norsk): R\u00f8d solhatt\nHerbal preparation(s)\nExpressed juice and dried expressed juice from fresh flowering aerial parts.\nEuropean Pharmacopoeia monograph reference\nN/A\nIndication(s)\nTraditional herbal medicinal product for treatment of small superficial wounds.\nThe product is a traditional herbal medicinal product for use in a specified indication exclusively based on long-standing use.\nType of tradition\nEuropean.\nSpecified strength\n10 to 20\u00a0g/100\u00a0g of expressed juice or equivalent amount of dried expressed juice in liquid or semi-solid dosage forms.\nSpecified posology\nAdolescents over the age of 12 years, adults, elderly\nSmall amount of ointment is applied on the affected area 2-3 times a day.\nThe use in children under 12 years of age is not recommended (see below \u201cSpecial warnings and precautions for use\u201d).\nRoute of administration\nCutaneous use.\nDuration of use or any restrictions on the duration of use\nDo not use the medicinal product for more than 1 week.\nIf the symptoms persist during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.\nAny other information necessary for the safe use\nContra-indications\nHypersensitivity to the active substance or to plants of the Asteraceae (Compositae) family.\nSpecial warnings and precautions for use\nIf signs of skin infection are observed, medical advice should be sought.\nThe use in children below 12 years of age is not recommended because a safe use has not been sufficiently documented.\nInteractions with other medicinal products and other forms of interaction\nNone reported.\nPregnancy and lactation\nThere are no data on cutaneous use during pregnancy or lactation.\nProducts containing Echinacea should not be applied to the breast of breastfeeding women.\nEffects on ability to drive and use machines\nNo studies on the effects on the ability to drive and use machines have been performed.\nUndesirable effects\nHypersensitive reactions (local rash, contact dermatitis, eczema and angioedema of the lips) may occur.\nThe frequency is not known.\nIf other adverse reactions not mentioned above occur, a doctor or a qualified healthcare practitioner should be consulted.\nOverdose\nNo case of overdose has been reported.\nCOMMUNITY LIST ENTRY ON ELEUTHEROCOCCUS SENTICOSUS (RUPR. ET MAXIM.) MAXIM., RADIX\nScientific name of the plant\nEleutherococcus senticosus (Rupr. et Maxim.) Maxim.\nBotanical family\nAraliaceae\nHerbal substance\nEleutherococcus root\nCommon name in all EU official languages of herbal substance\nBG (b\u0103lgarski): \u0435\u043b\u0435\u0443\u0442\u0435\u0440\u043e\u043a\u043e\u043a, \u043a\u043e\u0440\u0435\u043d\nCS (\u010de\u0161tina): eleuterokokov\u00fd ko\u0159en\nDA (dansk): Russisk rod\nDE (Deutsch): Taigawurzel\nEL (ellinik\u00e1): P\u03af\u03b6\u03b1 E\u03bb\u03b5\u03c5\u03b8\u03b5\u03c1\u03bf\u03ba\u03cc\u03ba\u03ba\u03bf\u03c5\nEN (English): Eleutherococcus root\nES (espa\u00f1ol): Eleuterococo, ra\u00edz de\nET (eesti keel): eleuterokokijuur\nFI (suomi): ven\u00e4j\u00e4njuuren juuri\nFR (fran\u00e7ais): racine d\u2019\u00e9leuth\u00e9rocoque (racine de ginseng sib\u00e9rien)\nHU (magyar): Szib\u00e9riai ginszeng gy\u00f6k\u00e9r (tajga gy\u00f6k\u00e9r)\nIT (italiano): Eleuterococco radice\nLT (lietuvi\u0173 kalba): Eleuterokok\u0173 \u0161aknys\nLV (latvie\u0161u valoda): Eleiterokoka sakne\nMT (malti): G\u0127erq ta\u2019 l-elewterokokku\nNL (nederlands): Russische ginsengwortel\nPL (polski): korze\u0144 eleuterokoka\nPT (portugu\u00eas): Raiz de Ginseng Siberiano\nRO (rom\u00e2n\u0103): R\u0103d\u0103cin\u0103 de ginseng siberian\nSK (sloven\u010dina): V\u0161ehojovcov\u00fd kore\u0148\nSL (sloven\u0161\u010dina): korenina elevterokoka\nSV (svenska): Rysk rot\nIS (\u00edslenska): S\u00edber\u00edu ginseng, r\u00f3t\nNO (norsk): Russisk rot\nHerbal preparation(s)\nComminuted herbal substance for preparation of a herbal tea\nLiquid extract (1:1, ethanol 30-40\u00a0% v/v)\nDry extract (13-25: 1, ethanol 28-40\u00a0% v/v)\nDry extract (17-30: 1, ethanol 70\u00a0% v/v)\nDry aqueous extract (15-17:1)\nTincture (1:5, ethanol 40\u00a0% v/v)\nEuropean Pharmacopoeia monograph reference\nEleutherococcus \u2014 Eleutherococci radix (ref.: 01/2008: 1419 corrected 6.0)\nIndication(s)\nTraditional herbal medicinal product for symptoms of asthenia such as fatigue and weakness.\nThe product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.\nType of tradition\nChinese, European.\nSpecified strength\nNot applicable.\nSpecified posology\nAdolescents over 12 years of age, adults, elderly\nHerbal preparations.\nDaily dose.\nComminuted herbal substance as herbal tea: 0,5-4\u00a0g.\nTea preparation: 0,5 to 4\u00a0g of comminuted herbal substance for infusion in 150\u00a0ml of boiling water.\nDosage frequency: 150\u00a0ml of tea infusion should be divided in one to three doses taken during the day.\nLiquid extract: 2-3\u00a0ml.\nDry extracts (ethanol 28-70\u00a0% v/v) corresponding to 0,5-4\u00a0g dried root.\nDry aqueous extract (15-17:1): 90-180\u00a0mg.\nTincture: 10-15\u00a0ml.\nThe daily dose can be taken in one to three doses.\nThe use is not recommended in children under 12 years of age (see below \u201cSpecial warnings and precautions for use\u201d).\nRoute of administration\nOral use.\nDuration of use or any restrictions on the duration of use\nNot to be taken for more than 2 months.\nIf the symptoms persist for more than 2 weeks during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.\nAny other information necessary for the safe use\nContra-indications\nHypersensitivity to the active substance.\nArterial hypertension.\nSpecial warnings and precautions for use\nThe use in children under 12 years of age is not recommended because sufficient experience is not available.\nIf the symptoms worsen during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.\nInteractions with other medicinal products and other forms of interaction\nNone reported.\nPregnancy and lactation\nSafety during pregnancy and lactation has not been established.\nIn the absence of sufficient data, the use during pregnancy and lactation is not recommended.\nEffects on ability to drive and use machines\nNo studies on the effect on the ability to drive and use machines have been performed.\nUndesirable effects\nInsomnia, irritability, tachycardia and headaches may occur. The frequency is not known.\nOverdose\nNo case of overdose has been reported.\u2019"}